Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

Journal of Nuclear Medicine February 2026, jnumed.123.266357; DOI: https://doi.org/10.2967/jnumed.123.266357 ...

Journal of Nuclear Medicine January 2026, jnumed.125.269933; DOI: https://doi.org/10.2967/jnumed.125.269933 ...

Journal of Nuclear Medicine September 2025, jnumed.124.268809; DOI: https://doi.org/10.2967/jnumed.124.268809 ...

Journal of Nuclear Medicine September 2025, jnumed.125.270807; DOI: https://doi.org/10.2967/jnumed.125.270807 ...

Continuous bed motion (CBM) for long–axial-field-of-view PET/CT enables swift total-body examination of patients. However, the sensitivity profile along the axial field of view (AFOV) varies ...

Journal of Nuclear Medicine August 2025, jnumed.124.268841; DOI: https://doi.org/10.2967/jnumed.124.268841 ...

Journal of Nuclear Medicine August 2025, jnumed.125.269671; DOI: https://doi.org/10.2967/jnumed.125.269671 ...

Solitary fibrous tumor (SFT) is a rare soft-tissue sarcoma with limited treatment options, especially in advanced or metastatic cases. Fibroblast activation protein α (FAPα) is overexpressed in ...

Journal of Nuclear Medicine July 2025, jnumed.125.270252; DOI: https://doi.org/10.2967/jnumed.125.270252 ...

Journal of Nuclear Medicine June 2025, jnumed.125.269457; DOI: https://doi.org/10.2967/jnumed.125.269457 Patients were scanned using the Biograph Vision digital PET ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252173; ...